Episode 45

full
Published on:

19th Feb 2025

Could biologic injectables change the eczema trajectory?

Could injectable drugs called "biologics" stop eczema by teaching a child's developing immune system to be less reactive? Dr. Amy Paller from Northwestern University Chicago and Dr. Elaine Siegfried from Saint Louis University in Missouri discuss stopping or tapering biologics and what happens to the immune system when we are on them. If you like our podcast, please consider supporting it with a tax deductible donation.

Research discussed

Clinical remission and therapy-free remission in pediatric patients with moderate-to-severe atopic dermatitis treated with dupilumab

Factors Associated with Remission of Eczema in Children

Persistence of Mild to Moderate Atopic Dermatitis

Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children

Show artwork for Eczema Breakthroughs

About the Podcast

Eczema Breakthroughs
Conversations between caregivers & the world’s cutting edge researchers.
Interviews with the leading scientists and innovators, hosted by Global Parents for Eczema Research (GPER), a non-profit led by parents of children with eczema.
Like what we're doing? Consider donating to GPER at: www.parentsforeczemaresearch.com/donate
Do you enjoy this podcast? Rate it on Apple Podcasts, Google Podcasts or Spotify!
Learn more about GPER and subscribe to this podcast at: parentsforeczemaresearch.org
Support This Show

About your host

Profile picture for korey capozza

korey capozza